XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
Phase 1
Active, not recruiting
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-10-13
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Sciwind Biosciences USA Co., Ltd.
- Target Recruit Count
- 152
- Registration Number
- NCT05579314
- Locations
- 🇺🇸
ICON - Early Development Services, Salt Lake City, Utah, United States
© Copyright 2025. All Rights Reserved by MedPath